Abstract
Background: Colon cancer is one of the most common cancers worldwide and has a poor prognosis. Through the analysis of transcriptome and clinical data of colon cancer, an immune gene-set signature was identified by single sample enrichment analysis (ssGSEA) scoring to predict patient survival and discover new therapeutic targets.
Objective: To study the role of immune gene-set signature in colon cancer.
Methods: First, RNASeq and clinical follow-up information were downloaded from The Cancer Genome Atlas (TCGA). Immune gene-related gene sets were collected from the ImmPort database. Genes and immunological pathways related to prognosis were screened in the training set and integrated for feature selection using random forest. The immune gene-related prognosis model was verified in the entire TCGA test set and GEO validation set and compared with immune cells scores and matrix score.
Results: A total of 1650 prognostic genes and 13 immunological pathways were identified. These genes and pathways are closely related to the development of tumors. 13-immune gene-set signature was established, which is an independent prognostic factor for patients with colon cancer. Risk stratification of samples could be carried out in the training set, test set, and external validation set. The AUC of five-year survival in the training set and validation set is greater than 0.6. Immunosuppression occurs in high-risk samples and compared with published models, riskScore has a better prediction effect.
Conclusion: This study constructed a 13-immune gene-set signature as a new prognostic marker to predict the survival of patients with colon cancer, and provided new diagnostic/prognostic biomarkers and therapeutic targets for colon cancer.
Keywords: Bioinformatics, prognostic markers, TCGA, colon cancer, biomarker, cell mutation.
Combinatorial Chemistry & High Throughput Screening
Title:A 13-Immune Gene Set Signature for Prediction of Colon Cancer Prognosis
Volume: 24 Issue: 8
Author(s): Zhuo Lu, Jin Chen, JiongYi Yan, QiaoMing Liu, Fang Li, WanNa Xiong, Shida Lin, Kai Yu* Jianqin Liang*
Affiliation:
- College of Life Science and Technology, Guangxi University, Nanning, Nanning, 530004,China
- Department of Pharmacy, Guangxi University of Traditional Chinese Medicine, Nanning City, Guangxi Province, 530001,China
Keywords: Bioinformatics, prognostic markers, TCGA, colon cancer, biomarker, cell mutation.
Abstract:
Background: Colon cancer is one of the most common cancers worldwide and has a poor prognosis. Through the analysis of transcriptome and clinical data of colon cancer, an immune gene-set signature was identified by single sample enrichment analysis (ssGSEA) scoring to predict patient survival and discover new therapeutic targets.
Objective: To study the role of immune gene-set signature in colon cancer.
Methods: First, RNASeq and clinical follow-up information were downloaded from The Cancer Genome Atlas (TCGA). Immune gene-related gene sets were collected from the ImmPort database. Genes and immunological pathways related to prognosis were screened in the training set and integrated for feature selection using random forest. The immune gene-related prognosis model was verified in the entire TCGA test set and GEO validation set and compared with immune cells scores and matrix score.
Results: A total of 1650 prognostic genes and 13 immunological pathways were identified. These genes and pathways are closely related to the development of tumors. 13-immune gene-set signature was established, which is an independent prognostic factor for patients with colon cancer. Risk stratification of samples could be carried out in the training set, test set, and external validation set. The AUC of five-year survival in the training set and validation set is greater than 0.6. Immunosuppression occurs in high-risk samples and compared with published models, riskScore has a better prediction effect.
Conclusion: This study constructed a 13-immune gene-set signature as a new prognostic marker to predict the survival of patients with colon cancer, and provided new diagnostic/prognostic biomarkers and therapeutic targets for colon cancer.
Export Options
About this article
Cite this article as:
Lu Zhuo , Chen Jin , Yan JiongYi , Liu QiaoMing , Li Fang, Xiong WanNa, Lin Shida , Yu Kai *, Liang Jianqin *, A 13-Immune Gene Set Signature for Prediction of Colon Cancer Prognosis, Combinatorial Chemistry & High Throughput Screening 2021; 24 (8) . https://dx.doi.org/10.2174/1386207323666200930104744
DOI https://dx.doi.org/10.2174/1386207323666200930104744 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
Call for Papers in Thematic Issues
Artificial Intelligence Methods for Biomedical, Biochemical and Bioinformatics Problems
Recently, a large number of technologies based on artificial intelligence have been developed and applied to solve a diverse range of problems in the areas of biomedical, biochemical and bioinformatics problems. By utilizing powerful computing resources and massive amounts of data, methods based on artificial intelligence can significantly improve the ...read more
Eco-friendly Agents for Biological Control of Pathogenic Diseases
The discovery of an alternative biological approach to disease management includes work on medicinal products derived from natural sources as a starting point for the development of eco-friendly agents for these diseases and the injuries they cause, as well as reducing human contact with hazardous chemicals and their residues. We ...read more
Emerging trends in diseases mechanisms, noble drug targets and therapeutic strategies: focus on immunological and inflammatory disorders
Recently infectious and inflammatory diseases have been a key concern worldwide due to tremendous morbidity and mortality world Wide. Recent, nCOVID-9 pandemic is a good example for the emerging infectious disease outbreak. The world is facing many emerging and re-emerging diseases out breaks at present however, there is huge lack ...read more
Exploring Spectral Graph Theory in Combinatorial Chemistry
Scope of the Thematic Issue: Combinatorial chemistry involves the synthesis and analysis of a large number of diverse compounds simultaneously. Traditional methods rely on brute force experimentation, which can be time-consuming and resource-intensive. Spectral Graph Theory, a branch of mathematics dealing with the properties of graphs in relation to the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Use of Ligands in Copper-Catalyzed [3+2] Azide-Alkyne Cycloaddition: Clicker than Click Chemistry?
Current Organic Chemistry Novel Approaches to Cancer Therapy Using Oncolytic Viruses
Current Molecular Medicine Synthesis, Characterization and Antimicrobial Activity of Pyridine-3- Carbonitrile Derivatives
Current Bioactive Compounds Medicinal Chemistry and Anti-Inflammatory Activity of Nitric Oxide-Releasing NSAI Drugs
Mini-Reviews in Medicinal Chemistry DNA Microarrays: Perspectives for Hypothesis-Driven Transcriptome Research and for Clinical Applications
Current Genomics Volumes and Surface Areas: Geometries and Scaling Relationships between Coarse- Grained and Atomic Structures
Current Pharmaceutical Design Beneficial Effect of Peptides from Microalgae on Anticancer
Current Protein & Peptide Science Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Genetic and Pharmacogenetic Aspects of Alcohol-Dependence
Current Pharmacogenomics Production of Alpha Emitters for Targeted Alpha Therapy
Current Radiopharmaceuticals Recent Advances in Raman Analysis of Plants: Alkaloids, Carotenoids, and Polyacetylenes
Current Analytical Chemistry Anticancer Activity of Ferrocenylthiosemicarbazones
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Urease Inhibitory Activity of Some 5-Aminomethylene Barbituric/Thiobarbituric Acid Derivatives
Letters in Drug Design & Discovery Human Aurora / Ipl1p Related Kinases
Current Genomics Αlpha-2 Adrenergic and Opioids Receptors Participation in Mice Gastroprotection of Abelmoschus esculentus Lectin
Current Pharmaceutical Design Topical Applications of Ozone and Ozonated Oils as Anti-Infective Agents: An Insight into the Patent Claims
Recent Patents on Anti-Infective Drug Discovery Systemic Sclerosis: Clinical Manifestations
Current Rheumatology Reviews Pharmacogenetics of Opioids for the Treatment of Acute Maternal Pain During Pregnancy and Lactation
Current Drug Metabolism Aspirin and Other Non-Steroidal Anti-Inflammatory Drugs as Cyclooxygenase Inhibitors: State of the Art, Barriers and Perspectives
Current Computer-Aided Drug Design MicroRNAs Involved in Oxidative Stress Processes Regulating Physiological and Pathological Responses
MicroRNA